Effects of the topical treatment with NSAIDs on corneal sensitivity and ocular surface of Sjögren's syndrome patients

被引:0
|
作者
P Aragona
A Stilo
F Ferreri
M Mobrici
机构
[1] Section of Ophthalmology,Department of Surgical Science
[2] University of Messina,undefined
来源
Eye | 2005年 / 19卷
关键词
indomethacin; diclofenac; corneal sensitivity; corneal epithelial defects; Sjögren's syndrome;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:535 / 539
页数:4
相关论文
共 50 条
  • [31] Heart Rate Variability in Patients with Sjögren’s Syndrome
    B. Tumiati
    F. Perazzoli
    A. Negro
    M. Pantaleoni
    G. Regolisti
    Clinical Rheumatology, 2000, 19 : 477 - 480
  • [32] Characterization of cognitive dysfunction in Sjögren’s syndrome patients
    Lynn C. Epstein
    Gina Masse
    Jerold S. Harmatz
    Tammy M. Scott
    Athena S. Papas
    David J. Greenblatt
    Clinical Rheumatology, 2014, 33 : 511 - 521
  • [33] Immunological abnormality and regulation in patients with Sjögren's syndrome
    T Sumida
    Arthritis Res Ther, 5
  • [34] Efficacy prediction of cevimeline in patients with Sjögren’s syndrome
    Hiroyuki Yamada
    Yoichi Nakagawa
    Ei Wakamatsu
    Takayuki Sumida
    Shigeo Yamachika
    Yoshiaki Nomura
    Kenji Mishima
    Ichiro Saito
    Clinical Rheumatology, 2007, 26 : 1320 - 1327
  • [36] Obesity: Friend or Foe in Sjögren's Syndrome Patients?
    Mezei, Kincso
    Nagy, Laura
    Orosz, Viktoria
    Aradi, Zsofia
    Boi, Bernadett
    Szanto, Antonia
    DIAGNOSTICS, 2024, 14 (23)
  • [37] Evaluation of Swallowing Functions in Patients with Sjögren’s Syndrome
    Sibel Eyigör
    Baha Sezgin
    Gonca Karabulut
    Kerem Öztürk
    Sercan Göde
    Tayfun Kirazlı
    Dysphagia, 2017, 32 : 271 - 278
  • [38] Successful treatment of a patient with primary Sjögren's syndrome with Rituximab
    Troels Ring
    Maria Kallenbach
    Jeppe Prætorius
    Søren Nielsen
    Birgitte Melgaard
    Clinical Rheumatology, 2006, 25 : 891 - 894
  • [39] Inhibitors of T cell Activation in the Treatment of Sjögren’s Syndrome
    Sabine Adler
    Peter M. Villiger
    Current Treatment Options in Rheumatology, 2015, 1 (3) : 269 - 276
  • [40] Epratuzumab shows promise in the treatment of primary Sjögren's syndrome
    Nature Clinical Practice Rheumatology, 2006, 2 (11): : 583 - 583